United States · FDA National Drug Code directory
Orphenadrine Citrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-9138_6f3f9e9c-bc37-4417-b785-324bf4869353
- Product NDC
- 68788-9138
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Orphenadrine Citrate
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19980619
- Source listing expiry
- 20271231
Source-listed ingredients
- ORPHENADRINE CITRATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9138-1) · 68788-9138-1
- 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9138-2) · 68788-9138-2
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9138-3) · 68788-9138-3
- 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9138-4) · 68788-9138-4
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9138-6) · 68788-9138-6
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9138-8) · 68788-9138-8
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9138-9) · 68788-9138-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →